Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications.

Advancing age is characterized by impairment in the function of the many regulatory processes that provide functional integration between cells and organs. Therefore, there may be a failure to maintain homeostasis under conditions of physiological stress. The reduced homeostatic ability affects different regulatory systems in different subjects, thus explaining at least partly the increased interindividual variability occurring as people get older. Important pharmacokinetic and pharmacodynamic changes occur with advancing age. Pharmacokinetic changes include a reduction in renal and hepatic clearance and an increase in volume of distribution of lipid soluble drugs (hence prolongation of elimination half-life) whereas pharmacodynamic changes involve altered (usually increased) sensitivity to several classes of drugs such as anticoagulants, cardiovascular and psychotropic drugs. This review focuses on the main age-related physiological changes affecting different organ systems and their implications for pharmacokinetics and pharmacodynamics of drugs.

[1]  I. Samloff,et al.  Age- and sex-related behaviour of gastric acid secretion at the population level. , 1982, Scandinavian journal of gastroenterology.

[2]  J S Harmatz,et al.  Diazepam disposition determinants , 1980, Clinical pharmacology and therapeutics.

[3]  D. Greenblatt,et al.  Lorazepam kinetics in the elderly , 1979, Clinical pharmacology and therapeutics.

[4]  D. Greenblatt,et al.  Age Does Not Alter Acetaminophen Absorption , 1982, Journal of the American Geriatrics Society.

[5]  N. Hollenberg,et al.  Age as a determinant of renal sodium conservation in normal man. , 1976, The Journal of laboratory and clinical medicine.

[6]  G. Corazza,et al.  Ageing and small-bowel mucosa: a morphometric study. , 1986, Gerontology.

[7]  L. Benet,et al.  Changes in plasma protein binding have little clinical relevance , 2002, Clinical pharmacology and therapeutics.

[8]  P. Duke,et al.  Age‐related morphine kinetics , 1983, Clinical pharmacology and therapeutics.

[9]  T. A. Anderson,et al.  The effect of dietary sodium chloride on blood pressure, body fluids, electrolytes, renal function, and serum lipids of normotensive man. , 1976, The Journal of laboratory and clinical medicine.

[10]  R. Branch,et al.  Effect of aging and cigarette smoking on antipyrine and indocyanine green elimination , 1979, Clinical pharmacology and therapeutics.

[11]  D. Greenblatt,et al.  Antipyrine absorption and disposition in the elderly. , 1988, Pharmacology.

[12]  G. Ford,et al.  Effect of 'autonomic blockade' on cardiac beta-adrenergic chronotropic responsiveness in healthy young, healthy elderly and endurance-trained elderly subjects. , 1994, Clinical science.

[13]  E. Lebenthal Pancreatic function and disease in infancy and childhood. , 1978, Advances in pediatrics.

[14]  L. Benet,et al.  Absorption and disposition of two combination formulations of hydrochlorothiazide and triamterene: Influence of age and renal function , 1986, Clinical pharmacology and therapeutics.

[15]  Agustin Castellanos,et al.  CLINICAL CARDIAC ELECTROPHYSIOLOGY: TECHNIQUES AND INTERPRETATIONS , 1980 .

[16]  Emerging strategies in Parkinson's disease. Report of a symposium. Chicago, March 24, 1990. Proceedings. , 1990, Neurology.

[17]  J. Miners,et al.  Comparison of paracetamol metabolism in young adult and elderly males , 2004, European Journal of Clinical Pharmacology.

[18]  J. Leeming,et al.  The appearance of the small bowel mucosa in old age. , 1975, Age and ageing.

[19]  J. Fries Aging, Illness, and Health Policy: Implications of the Compression of Morbidity , 2015, Perspectives in biology and medicine.

[20]  B. Rolls,et al.  Altered water excretion in healthy elderly men. , 1987, Age and ageing.

[21]  R. Branch,et al.  Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (librium). , 1978, Gastroenterology.

[22]  A. Bender,et al.  THE EFFECT OF INCREASING AGE ON THE DISTRIBUTION OF PERIPHERAL BLOOD FLOW IN MAN. , 1966, Journal of the American Geriatrics Society.

[23]  L. Wollner,et al.  Reduced thirst after water deprivation in healthy elderly men. , 1984, The New England journal of medicine.

[24]  N. Hockings,et al.  Factors affecting the response to inhibition of drug metabolism by cimetidine--dose response and sensitivity of elderly and induced subjects. , 1984, British journal of clinical pharmacology.

[25]  R. Davies,et al.  An overview of the clinical pharmacology of enalapril. , 1984, British journal of clinical pharmacology.

[26]  S. Schenker,et al.  Effects of aging and liver disease on disposition of lorazepam , 1978, Clinical pharmacology and therapeutics.

[27]  D. Fliser,et al.  Renal handling of drugs in the healthy elderly Creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged , 1999, European Journal of Clinical Pharmacology.

[28]  J. Kampmann,et al.  Effect of age on liver function. , 1975, Geriatrics.

[29]  A. Redolfi,et al.  Blood level of cimetidine in relation to age , 1979, European Journal of Clinical Pharmacology.

[30]  J. Fleg,et al.  Effects of Age and Aerobic Capacit on Arterial Stiffness in Healthy Adults , 1993, Circulation.

[31]  B. McEwen,et al.  Prolonged glucocorticoid exposure reduces hippocampal neuron number: implications for aging , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[32]  H. Wynne,et al.  The association of age and frailty with paracetamol conjugation in man. , 1990, Age and ageing.

[33]  R. D. Montgomery,et al.  AGE CHANGES IN SMALL-INTESTINAL MUCOSA , 1978, The Lancet.

[34]  S. Husted,et al.  The influence of age on renal and extrarenal effects of frusemide. , 1984, British journal of clinical pharmacology.

[35]  H. Wynne,et al.  The effect of age upon liver volume and apparent liver blood flow in healthy man , 1989, Hepatology.

[36]  D. Greenblatt,et al.  Cimetidine Impairs Clearance of Antipyrine and Desmethyldiazepam in the Elderly , 1982, Journal of the American Geriatrics Society.

[37]  A. Shepherd,et al.  Reduced induction of drug metabolism in the elderly. , 1978, Age and Ageing.

[38]  H. Creasey,et al.  Gastric Emptying Rate in the Elderly: Implications for Drug Therapy , 1981, Journal of the American Geriatrics Society.

[39]  B. K. Park,et al.  Aging and drug interactions. I. Effect of cimetidine and smoking on the oxidation of theophylline and cortisol in healthy men. , 1987, The Journal of pharmacology and experimental therapeutics.

[40]  K. Sabanathan,et al.  A comparative study of the pharmacokinetics and pharmacodynamics of atenolol, hydrochlorothiazide and amiloride in normal young and elderly subjects and elderly hypertensive patients , 2004, European Journal of Clinical Pharmacology.

[41]  J. Lavan,et al.  Theophylline kinetics in relation to age: the importance of smoking. , 1980, British journal of clinical pharmacology.

[42]  T. Fülöp,et al.  Body composition in elderly people. II. Comparison of measured and predicted body composition in healthy elderly subjects. , 1985, Gerontology.

[43]  C. J. Jones,et al.  Pharmacokinetics of azapropazone in the elderly. , 1982, British journal of clinical pharmacology.

[44]  V. Portnoi Digitalis Delirium in Elderly Patients , 1979, Journal of clinical pharmacology.

[45]  J. Crooks,et al.  Effect of Age and Sex on Human Drug Metabolism , 1971, British medical journal.

[46]  D. Abernethy,et al.  Responses to intravenous and oral diltiazem in elderly and younger patients with systemic hypertension. , 1987, The American journal of cardiology.

[47]  O'Neill Pa,et al.  Water homeostasis and ageing. , 1992 .

[48]  R. Yuan,et al.  Effect of chronic renal failure on the disposition of highly hepatically metabolized drugs. , 2000, International journal of clinical pharmacology and therapeutics.

[49]  A. Fitton,et al.  Perindopril. A review of its pharmacological properties and therapeutic use in cardiovascular disorders. , 1991, Drugs.

[50]  C. Roberts,et al.  Drug induction of hepatic enzymes in the elderly. , 1984, Age and ageing.

[51]  J. M. Johnson,et al.  Absorption and disposition of ampicillin in the elderly , 1980, European Journal of Clinical Pharmacology.

[52]  J. Kelly,et al.  Clinical Pharmacokinetics of the Newer ACE Inhibitors , 1990, Clinical pharmacokinetics.

[53]  T. Blaschke,et al.  Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. , 1986, The Journal of pharmacology and experimental therapeutics.

[54]  M. Mclachlan THE AGEING KIDNEY , 1978, The Lancet.

[55]  R. Tandon,et al.  The efficacy, safety, and tolerability of antipsychotics in the elderly. , 1999, The Journal of clinical psychiatry.

[56]  H. Necheles,et al.  STUDIES IN OLD AGE: IV. THE CLINICAL SIGNIFICANCE OF SALIVARY, GASTRIC AND PANCREATIC SECRETION IN THE AGED , 1940 .

[57]  C. George,et al.  The effect of ageing on the hepatic clearance of propranolol. , 1979, British journal of clinical pharmacology.

[58]  K. Engedal,et al.  The patterns of motility are maintained in the human small intestine throughout the process of aging. , 1992, Scandinavian journal of gastroenterology.

[59]  J. Biollaz,et al.  Pharmacokinetic Optimisation of Angiotensin Converting Enzyme (ACE) Inhibitor Therapy , 1992, Clinical Pharmacokinetics.

[60]  A. Chedid,et al.  Aging Liver , 2002, Gerontology.

[61]  J. Schwartz Calcium Antagonists in the Elderly , 1996, Drugs & aging.

[62]  R. Nation,et al.  Lignocaine kinetics in cardiac patients and aged subjects. , 1977, British journal of clinical pharmacology.

[63]  E. Lakatta,et al.  The aging process. , 1990, Annals of internal medicine.

[64]  R. Cody,et al.  Age-related hemodynamic, renal, and hormonal differences among patients with congestive heart failure. , 1989, Archives of internal medicine.

[65]  C. Swift,et al.  Serum cystatin C is not a better marker of creatinine or digoxin clearance than serum creatinine. , 2002, British journal of clinical pharmacology.

[66]  A. Renwick,et al.  Age-related changes in the pharmacokinetics and pharmacodynamics of nifedipine. , 1988, British journal of clinical pharmacology.

[67]  C. Hunt,et al.  Hepatic cytochrome P-4503A (CYP3A) activity in the elderly , 1992, Mechanisms of Ageing and Development.

[68]  D. Harman Aging: Phenomena and Theories , 1998, Annals of the New York Academy of Sciences.

[69]  T. Kampmann,et al.  Dose regimen of kanamycin and gentamicin. , 2009, Acta medica Scandinavica.

[70]  T. Moreland,et al.  Age as a determinant of sensitivity to warfarin. , 1977, British journal of clinical pharmacology.

[71]  N W Shock,et al.  Longitudinal Studies on the Rate of Decline in Renal Function with Age , 1985, Journal of the American Geriatrics Society.

[72]  D. L. Schmucker Liver Function and Phase I Drug Metabolism in the Elderly , 2001, Drugs & aging.

[73]  C H Chen,et al.  Coupled systolic-ventricular and vascular stiffening with age: implications for pressure regulation and cardiac reserve in the elderly. , 1998, Journal of the American College of Cardiology.

[74]  A. Somogyi,et al.  Amiloride disposition in geriatric patients: importance of renal function. , 1990, British journal of clinical pharmacology.

[75]  C. Swift,et al.  Single dose pharmacokinetics and pharmacodynamics of oral loprazolam in the elderly. , 1985, British journal of clinical pharmacology.

[76]  A. Gelb,et al.  Aging and gastrointestinal physiology. , 1999, Clinics in geriatric medicine.

[77]  D. L. Madsen,et al.  Effects of gender, age, and body mass index on gastrointestinal transit times , 1992, Digestive Diseases and Sciences.

[78]  G. Tucker,et al.  In-vivo indices of enzyme activity: the effect of renal impairment on the assessment of CYP2D6 activity. , 1999, Pharmacogenetics.

[79]  Stephen L. Johnson,et al.  Gastrointestinal absorption as a function of age: Xylose absorption in healthy adults , 1985, Clinical pharmacology and therapeutics.

[80]  Meyerowitz Br Renal function in aging. , 1989 .

[81]  Wolfgang H. H. Kruse Problems and Pitfalls in the Use of Benzodiazepines in the Elderly , 1990, Drug safety.

[82]  C. Kaye,et al.  The effect of age on plasma levels of propranolol and practolol in man. , 1975, British journal of clinical pharmacology.

[83]  A. Garvey,et al.  Absence of an age effect on sulfobromophthalein retention in healthy men. , 1973, Gastroenterology.

[84]  J. Graff,et al.  Gastrointestinal mean transit times in young and middle-aged healthy subjects. , 2001, Clinical physiology.

[85]  A. Ljungqvist,et al.  Normal intrarenal arterial pattern in adult and ageing human kidney. A microangiographical and histological study. , 1962, Journal of anatomy.

[86]  M. Dunnill,et al.  Some observations on the quantitative anatomy of the kidney , 1973, The Journal of pathology.

[87]  C. George,et al.  Increased sensitivity to nitrazepam in old age. , 1977, British medical journal.

[88]  R. Tracy,et al.  The action of aging upon coronary intima and renal microvasculature in USA and Andes populations , 2002, Mechanisms of Ageing and Development.

[89]  P Laippala,et al.  Physiological factors and medications as predictors of injurious falls by elderly people: a prospective population-based study. , 1996, Age and ageing.

[90]  J. Fleg,et al.  Exercise cardiac output is maintained with advancing age in healthy human subjects: cardiac dilatation and increased stroke volume compensate for a diminished heart rate. , 1984, Circulation.

[91]  T. Fülöp,et al.  Body composition in elderly people. I. Determination of body composition by multiisotope method and the elimination kinetics of these isotopes in healthy elderly subjects. , 1985, Gerontology.

[92]  B. R. Meyer Renal Function in Aging , 1989, Journal of the American Geriatrics Society.

[93]  C. Swift,et al.  Responsiveness to oral diazepam in the elderly: relationship to total and free plasma concentrations. , 1985, British journal of clinical pharmacology.

[94]  K. O’malley,et al.  Digoxin in the elderly: Pharmacokinetic consequences of old age , 1979, Clinical pharmacology and therapeutics.

[95]  A. H. Norris,et al.  Aging and ethanol metabolism , 1977, Clinical pharmacology and therapeutics.

[96]  N. Friedland,et al.  The Effect of Age and Sex Upon Human Pancreatic Secretion of Fluid and Bicarbonate , 1966 .

[97]  D. Greenblatt,et al.  Kinetics and dynamics of single doses of oxazepam in the elderly: implications of absorption rate. , 1986, The Journal of clinical psychiatry.

[98]  J S Harmatz,et al.  Oxazepam kinetics: effects of age and sex. , 1980, The Journal of pharmacology and experimental therapeutics.

[99]  Jerome J. Schentag,et al.  Relationship between concentration and anticoagulant effect of heparin in plasma of hospitalized patients: Magnitude and predictability of interindividual differences * , 1980, Clinical pharmacology and therapeutics.

[100]  F. Leblond,et al.  Drug metabolism in chronic renal failure. , 2003, Current drug metabolism.

[101]  E. Lakatta Heart and Circulation , 1990 .

[102]  K. Nair,et al.  Age effect on fibrinogen and albumin synthesis in humans. , 1998, The American journal of physiology.

[103]  G. Hawksworth,et al.  A comparison of the pharmacokinetics of atenolol, metoprolol, oxprenolol and propranolol in elderly hypertensive and young healthy subjects. , 1985, British journal of clinical pharmacology.

[104]  B. K. Park,et al.  Aging and drug interactions. II. Effect of phenytoin and smoking on the oxidation of theophylline and cortisol in healthy men. , 1988, The Journal of pharmacology and experimental therapeutics.

[105]  D. Greenblatt,et al.  Sensitivity to triazolam in the elderly. , 1991, The New England journal of medicine.

[106]  C. Swift,et al.  The association of age with gastric emptying. , 1993, Age and Ageing.

[107]  P. McKenna,et al.  Pharmacological Management of Schizophrenia in Older Patients , 1994, Drugs & aging.

[108]  T Opthof,et al.  The normal range and determinants of the intrinsic heart rate in man. , 2000, Cardiovascular research.

[109]  H. Elliott Alpha 1-adrenoceptor responsiveness: the influence of age. , 1988, Journal of cardiovascular pharmacology.

[110]  M. Wilson,et al.  Activity of the hypothalamic-pituitary-adrenal axis is altered by aging and exposure to social stress in female rhesus monkeys. , 2000, The Journal of clinical endocrinology and metabolism.

[111]  M. Halliwell,et al.  Antipyrine disposition and liver size in the elderly , 1978, European Journal of Clinical Pharmacology.

[112]  C. Hunt,et al.  Effect of age and gender on the activity of human hepatic CYP3A. , 1992, Biochemical pharmacology.

[113]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[114]  D. Greenblatt,et al.  Kinetics and clinical effects of flurazepam in young and elderly noninsomniacs , 1981, Clinical pharmacology and therapeutics.

[115]  R. Vestal,et al.  Reduced β‐adrenoceptor sensitivity in the elderly , 1979 .

[116]  F. Gribnau,et al.  Furosemide kinetics and dynamics in aged patients , 1983, Clinical pharmacology and therapeutics.

[117]  D F DAVIES,et al.  Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. , 1950, The Journal of clinical investigation.

[118]  L. Thal,et al.  The Lewy body variant of Alzheimer's disease , 1990, Neurology.

[119]  G. Ewy,et al.  Digoxin Metabolism in the Elderly , 1969, Circulation.

[120]  P. Newbury,et al.  Age as a factor affecting lithium therapy. , 1977, British journal of clinical pharmacology.

[121]  F. Andreasen,et al.  Influence of age and sex on the pharmacokinetics of thiopentone. , 1981, British journal of anaesthesia.

[122]  M. Reidenberg,et al.  Relationship between diazepam dose, plasma level, age, and central nervous system depression , 1978, Clinical pharmacology and therapeutics.

[123]  R. Oberbauer,et al.  Pharmacokinetics of Indomethacin in the Elderly , 1993, Clinical pharmacokinetics.

[124]  J S Harmatz,et al.  Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly , 2012, Clinical pharmacokinetics.